Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis

Background The clinical significance of tumor-specific genomic alterations in metastatic renal cell carcinoma (mRCC) is emerging, with several studies suggesting an association between PBRM1 mutations and response with immunotherapy (IO). We sought to determine genomic predictors of differential res...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Sumanta Pal, Paulo Gustavo Bergerot, Nazli Dizman, JoAnn Hsu, Yung Lyou, Nicholas Salgia, Daniel Enriquez, Tyler Izatt, Jeffrey M Trent, Sara Byron
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMJ Publishing Group 2020-10-01
Reeks:	Journal for ImmunoTherapy of Cancer
Online toegang:	https://jitc.bmj.com/content/8/2/e000953.full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!